1
Return

Optimizing Hepatitis C Virus Antibody Testing Strategy and Setting: Results From a Large Real-World Screening Program

delete2026-07-01
delete0
delete
OA
AI
G
Grishma Hirode
C
Camelia Capraru
A
Aaron Vanderhoff
A
Andrew B Mendlowitz
B
Brett Wolfson-Stofko
J
Joel Karkada
D
David Smookler
M
Mediongo-Abasi Usoro
S
Steven M Friedman
K
Kathy Bates
T
Tony Mazzulli
J
Joshua V Juan
H
Hemant Shah
B
Bettina E Hansen
H
Harry L A Janssen
M
Mia J Biondi
J
Jordan J Feld *
DOI：10.1093/ofid/ofag218delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Optimal hepatitis C virus (HCV) screening is required to prevent transmission and progression to advanced liver disease and to meet global elimination targets. While administrative health data can highlight trends in testing and treatment, additional information is required to understand barriers in the care cascade. We conducted a real-world analysis documenting the care cascade and the effectiveness of HCV antibody (Ab) screening modalities across different community and clinical settings.

Journal

Open Forum Infectious Diseases cover
Open Forum Infectious Diseases
IF:
3.8
Papers:
6.3K
Citations:
1.4W

Organization

A
albany medical clinic
Scholars:
2
Papers: 1
Citations: 0
E
erasmus mc university medical center
Scholars:
163
Papers: 51
Citations: 0
U
university health network
Scholars:
2.3K
Papers: 802
Citations: 5
U
university of toronto
Scholars:
14.5W
Papers: 11.9W
Citations: 165
Cited Papers

Cited Papers

Citing Papers

Citing Papers